At-home Expansion Leverage the at-home collection launch for MyProstateScore 2.0 to reach patients beyond traditional clinics and partner with primary care networks, telemedicine platforms, and employer health programs to expand adoption and improve screening adherence.

Global Expansion With presence in the United Kingdom and Europe, pursue international sales by establishing distributors or direct channels, align with local regulatory and reimbursement frameworks, and collaborate with regional urology centers to validate and promote the test.

Workflow Integration Position MyProstateScore 2.0 as a value-add in hospital workflows by targeting urology, oncology, and radiology departments, offering EHR/LIS interoperability and decision-support integrations, backed by payer-backed pilots and outcome data.

Laboratory Scaleup Capitalize on the recent liquid-handling asset acquisition to enable high-throughput testing; pursue contract diagnostics, CRO partnerships, and cross-sell screening services to large health systems and research programs.

Market Positioning Leverage active conference presence and digital marketing capabilities to build physician engagement programs, publish compelling case studies, and execute value-driven selling plays aimed at large integrated delivery networks and regional health systems.